BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 31729202)

  • 1. The use of procalcitonin for the management of sepsis in Internal Medicine wards: current evidence.
    Tosoni A; Paratore M; Piscitelli P; Addolorato G; De Cosmo S; Mirijello A;
    Panminerva Med; 2020 Mar; 62(1):54-62. PubMed ID: 31729202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin-guided antibiotic therapy for suspected and confirmed sepsis of patients in a surgical trauma ICU: a prospective, two period cross-over, interventional study.
    Chomba RN; Moeng MS; Lowman W
    S Afr J Surg; 2020 Sep; 5(3):143-149. PubMed ID: 33231007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin-guided antibiotic therapy: an expert consensus.
    Bartoletti M; Antonelli M; Bruno Blasi FA; Casagranda I; Chieregato A; Fumagalli R; Girardis M; Pieralli F; Plebani M; Rossolini GM; Sartelli M; Viaggi B; Viale P; Viscoli C; Pea F
    Clin Chem Lab Med; 2018 Jul; 56(8):1223-1229. PubMed ID: 29874192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to: implement procalcitonin testing in my practice.
    Neeser O; Branche A; Mueller B; Schuetz P
    Clin Microbiol Infect; 2019 Oct; 25(10):1226-1230. PubMed ID: 30616016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature.
    Covington EW; Roberts MZ; Dong J
    Pharmacotherapy; 2018 May; 38(5):569-581. PubMed ID: 29604109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis.
    Collins CD; Brockhaus K; Sim T; Suneja A; Malani AN
    Am J Health Syst Pharm; 2019 Aug; 76(16):1219-1225. PubMed ID: 31369118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
    Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis.
    Schuetz P; Raad I; Amin DN
    Curr Opin Crit Care; 2013 Oct; 19(5):453-60. PubMed ID: 23817026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of a standardized PCT-algorithm reduces costs in intensive care in septic patients - a DRG-based simulation model.
    Wilke MH; Grube RF; Bodmann KF
    Eur J Med Res; 2011 Dec; 16(12):543-8. PubMed ID: 22112361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
    Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
    Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin to guide antibiotic decision making.
    Branche A; Neeser O; Mueller B; Schuetz P
    Curr Opin Infect Dis; 2019 Apr; 32(2):130-135. PubMed ID: 30648993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Abbott Architect BRAHMS and the Biomérieux Vidas BRAHMS Procalcitonin Assays.
    Wang D; Caddell B; Nolte FS; Babic N
    J Appl Lab Med; 2019 Jan; 3(4):580-586. PubMed ID: 31639727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use.
    Schuetz P; Beishuizen A; Broyles M; Ferrer R; Gavazzi G; Gluck EH; González Del Castillo J; Jensen JU; Kanizsai PL; Kwa ALH; Krueger S; Luyt CE; Oppert M; Plebani M; Shlyapnikov SA; Toccafondi G; Townsend J; Welte T; Saeed K
    Clin Chem Lab Med; 2019 Aug; 57(9):1308-1318. PubMed ID: 30721141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to best use procalcitonin to diagnose infections and manage antibiotic treatment.
    Schuetz P
    Clin Chem Lab Med; 2023 Apr; 61(5):822-828. PubMed ID: 36317790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin: Between evidence and critical issues.
    Aloisio E; Dolci A; Panteghini M
    Clin Chim Acta; 2019 Sep; 496():7-12. PubMed ID: 31194966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a Combination Biomarker Algorithm To Identify Medical Intensive Care Unit Patients with Suspected Sepsis at Very Low Likelihood of Bacterial Infection.
    Han JH; Nachamkin I; Coffin SE; Gerber JS; Fuchs B; Garrigan C; Han X; Bilker WB; Wise J; Tolomeo P; Lautenbach E;
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6494-500. PubMed ID: 26239984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of procalcitonin outside of the Intensive Care Unit (ICU): a multidisciplinary approach.
    Fantoni M; Taddei E; Cauda R; Antonelli Incalzi R; Capone A; Cortese F; Sanguinetti M; Spandonaro F; Urbani A; Murri R
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2978-2985. PubMed ID: 31002168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin in special patient populations: Guidance for antimicrobial therapy.
    Smith SE; Muir J; Kalabalik-Hoganson J
    Am J Health Syst Pharm; 2020 May; 77(10):745-758. PubMed ID: 32340027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.